The thirst for a perfect switching device for ultra-low power applications results in an investigation of novel micro or nanoelectromechanical systems (M/NEMS) switches.
Jan 11, 2023
Quest for an ideal switching device for ultra-low power applications leads to an exploration of novel micro/nanoelectromechanical systems (M/NEMS) switches. This research has been driven by the superior performance of M/NEMS devices, such as ideal...
Jan 11, 2023
SCHOTT appointed Chris Cassidy, current president of SCHOTT Pharma USA, as president of SCHOTT North America. He will hold both positions. Cassidy joined SCHOTT North America in 2014 as vice president of the pharmaceutical systems business unit. I...
Jan 11, 2023
Tau and tubulin proteins are one of the leading causes of many neurodegenerative diseases, such as Alzheimer's and Parkinson's.
Jan 10, 2023
A new algorithm is probably not efficient enough to crack current encryption keys—but that’s no reason for complacency, researchers say
Jan 10, 2023
Technically complex, costly, and delicate to operate, supercontinuum generation is no easy endeavor. But its unique optical properties and efficient illumination combined with incremental advances in technology have further fueled demand for these...
Jan 10, 2023
Researchers present a special silicon nitride nanopore-based sensing device that is designed to provide volume information about tau and tubulin protein molecules and their aggregation states. To create the sensor, the team explored how the protei...
Jan 10, 2023
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Jan 10, 2023
To date, nanoparticles as catalysts for green hydrogen have been like rowers in an eight: researchers could only measure their average performance, but couldn't determine which one was the best. This has now changed following the development ...
Jan 10, 2023
Probing the tau and tubulin protein molecules behind Alzheimer's and Parkinson's.
Jan 10, 2023
